✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Neuland Laboratories Ltd.

NEULANDLAB

Market Cap
₹16,449 Cr.
P/E
54.85

Neuland Laboratories Ltd.

About
Neuland Laboratories is a prominent manufacturer of active pharmaceutical ingredients (APIs) and a comprehensive solution provider for the pharmaceutical industry's chemistry requirements. The company… Read more
Neuland Laboratories is a prominent manufacturer of active pharmaceutical ingredients (APIs) a… Read more
Low
5540
52W Range
High
18100
  • Neuland Laboratories
  • Gufic Biosciences
  • Alivus Life Sciences
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

11 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up - Custom Manufacturing Solutions(CMS)

Product Wise Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (.)
      Source
    • Global DMFs filed (.)
      Source
    • Total reactor capacity (kL)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    Suppliers
    • Bodhtree Consulting Ltd.
    Customers
    • Aurobindo Pharma Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • Lupin Ltd.
    • Novartis India Ltd.
    • Amneal Pharmaceuticals
    FAQs on Neuland Laboratories Ltd. Business

    Neuland Laboratories specializes in manufacturing APIs and providing comprehensive solutions for drug development and cGMP manufacturing in the pharmaceutical industry.

    Neuland Laboratories major competitors are Gufic Biosciences, Alivus Life Sciences, Granules India, AMI Organics, Shilpa Medicare, Aarti Pharmalabs, Supriya Lifescience.
    Market Cap of Neuland Laboratories is ₹16,449 Crs.
    While the median market cap of its peers are ₹6,679 Crs.

    Neuland Laboratories seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Mar Jun Sep Dec Mar Sep Dec
    Investor Presentation Mar Jun Sep Dec Mar Jun Sep Dec Feb Mar Jun Aug Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Sep Dec Mar Sep Dec Mar Sep Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Dec
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Neuland Laboratories Ltd.
    Neuland Labs Business Analysis| - Reaching Critical Mass - SOIC
    What Are Peptides? - SOIC
    Neuland Lab - Story Of Transformation - Sahil Sharma
    Neuland Labs - Detailed Analysis with Speciality APIs - Value Educator
    View the discussion on ValuePickr
    Why Neuland Is A Solid Business - UnseenValue
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material